Thoracic neuroblastoma  by Rudolf, Joseph William & Thapa, Mahesh
Case report
A 9-day-old female was referred to our hospital for 
evaluation of  a large left posterior mediastinal mass with 
thinning and bony destruction of  the 4th and 5th ribs as 
visualized by CT. The patient was born to a 28-year-old 
G3P2-3 mother via spontaneous vaginal delivery. The pa-
tient’s oxygen saturations were in the 70s after delivery. In 
the days following her birth, the patient was noted to have 
labored breathing and sweating upon feeding. A chest ra-
diograph was performed at an outside hospital, and it was 
mistakenly believed to show cardiomegaly and a large thy-
mus (Figs. 1A and 1B). Echocardiogram was unremarkable 
except for septal right ventricular hypertrophy and in-
creased pulmonary pressures. On the day the patient was 
referred to us, a chest CT revealed the mediastinal mass 
(Fig. 2). 
After the child was transferred to our facility, an MRI 
study showed a 2.4 x 4.7 x 2.9-cm heterogeneously enhanc-
ing mass in the left posterior mediastinum that extended 
through the neural foramen at multiple levels and that 
demonstrated a posterior extradural component within the 
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We describe the case of  a 9-day-old female referred for a left posterior mediastinal mass, which we diag-
nosed as a thoracic neuroblastoma (TNBL) by biopsy. We present this case report to illustrate the classic 
radiographic, CT, MRI, and nuclear-medicine features of  the disease. We believe it is an informative 
teaching resource for trainees and radiologists. TNBL is a solid childhood tumor of  neuroblast origin, 
which presents in children most often in the first years of  life. Treatment of  TNBL is largely directed by 
staging and the criteria for staging rely heavily on multimodal imaging—especially MRI and I-123 
metaiodobenzylguanidine (MIBG) bone scan.
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thoracic spine, deviating and flattening the spinal cord an-
teriorly from the T2 through T8 levels (Figs. 3A and 3B). 
The patient was immediately taken to the OR for thora-
cotomy with biopsy of  the chest mass as well as bilateral 
posterior iliac crest bone marrow aspirates and biopsies. 
Frozen sections demonstrated poorly differentiated histol-
ogy (shwannian-poor) with a low mitotic-karyorrhectic in-
dex (1%), and no amplification of  the N-MYC gene. Bone-
marrow biopsies were bilaterally negative for neuroblas-
toma metastasis. The infant was diagnosed with 
intermediate-risk neuroblastoma, a Hickman catheter was 
placed, and the patient was returned to the Infant Intensive 
Care Unit. The infant tolerated the procedure well without 
complication.
Radiation therapy was initiated four days after surgery, 
following marked decline in the patient’s neurologic func-
tion in the lower extremities. Her first cycle consisted of  
1080 cGy delivered in 180-cGy fractions. An I-123 MIBG 
scan, performed ten days after the surgery, showed intense 
uptake of  I-123 MIBG at the site of  the mediastinal mass 
(Fig. 4). No abnormal soft tissue or osseous MIBG uptake 
was observed. A second cycle of  carpoplatin and etoposide 
was started 16 days after initiation of  the radiation therapy.
Followup appointments approximately three months after 
the surgery showed a well-nourished, well-developed child, 
in no apparent distress. The patient’s father noted that the 
girl’s respiratory status was improving despite periodic stri-
dor and tachypnea. The infant was found to be moving her 
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Figure 2. 9-day-old infant with thoracic neuroblastoma. Axial 
contrast-enhanced CT scan through the mid-chest. A het-
erogeneously enhancing mass occupies the left posterior 
mediastinum (blue asterisk) with speckled calcifications (red 
arrowheads), neural foramen invasion (green arrow), and 
ipsilateral rib destruction. Note the anterior and righward 
deviation of the mediastinal structures.
Figure 3. 9-day-old infant with thoracic neuroblastoma. Axial 
T2 (A) and sagittal T1 postcontrast (B) images of the mass 
demonstrate an enhancing, T2 bright lesion in the left pos-
terior mediastinum (blue asterisk) with some calcifications 
(red arrowhead), and neural foramen invasion (green 
arrow).
extremities more. A care plan was established for future 
followup. MRI performed at this time showed 
improvement.
Discussion
TNBL is a solid tumor of  childhood composed of  highly 
heterogeneous neuroblasts originating along paraspinal 
areas of  the sympathetic nervous system (1, 2). Although 
thoracic neuroblastomas account for a minority of  all neu-
roblastoma cases (11-26%), they remain the most common 
mediastinal mass in patients less than two years of  age (3). 
TNBL has a relatively favorable prognosis and is generally 
associated with better outcomes than neuroblastomas aris-
ing in other areas (3, 4). Although the mechanism for the 
more favorable prognosis is unclear, it is known that tho-
racic neuroblastomas tend to be detected at an earlier age 
and present with a higher frequency of  localization at the 
time of  diagnosis when compared with nonthoracic 
neuroblastomas (3, 4).
Patients with TNBL may present with symptoms affect-
ing a variety of  organ systems: respiratory (infection, dis-
tress, pneumonia), neurologic (ataxia, Horner’s syndrome, 
myoclonic jerk), or urogenital (urinary tract infections) (5). 
However, the presentation is highly variable, and only half  
of  thoracic neuroblastoma patients with intraspinal exten-
sion are symptomatic at the time of  diagnosis (6). The aver-
age age at presentation is two years (5). Spontaneous regres-
sion is possible and can happen in up to 50% of  cases (7). 
However, this phenomenon seems to occur only in patients 
under two years of  age and is undocumented in older 
patients (5).
Preliminary imaging of  neuroblastoma patients is tar-
geted at addressing symptoms and may include chest and 
abdominal radiographs, skeletal films, abdominal 
ultrsound, or spinal MRI (1). Asymptomatic cases are often 
discovered by screening or as an incidental finding (2). In 
cases of  TNBL, a chest radiograph is sufficient to suggest 
diagnosis (6). However, multimodal imaging is necessary to 
assess the extent of  the disease. MRI is considered the best 
imaging modality for staging neuroblastomas due to its 
accuracy in determining nodal extension, intraspinal exten-
sion, and chest wall involvement (1, 6). On MRI, the tumor 
is typically heterogeneous in appearance, with variable en-
hancement and prolonged T1 and T2 relaxation times. In 
addition to MRI staging, an I-123 MIBG bone scan should 
be performed to look for distant disease (1, 2). Alternatively, 
I-131 may be used, but it is generally considered to be infe-
rior to I-123 in this application (1). In cases of  distant dis-
ease, dissemination occurs via the lymphatic circulation or 
hematogenously (2). Imaging of  the brain may be indicated 
in the presence of  neurologic symptoms (2). Differentiation 
between neuroblastoma, ganglioneuroblastoma, and gan-
glioneuroma may not be possible with imaging alone (1). 
TNBL cases are staged according to the International 
Neuroblastoma Staging System (INSS) (1, 2). Classification 
consists of  four stages that weigh the localization and re-
sectability of  the tumor. Patients may also be histologically 
stratified with either the Shimada or the Paediatric Oncol-
ogy Group (POG) classification systems (1, 2). The Shi-
mada system uses morphologic features and patient age at 
diagnosis, while the POG also considers INSS stage, DNA 
index, and MYCN amplification status (2).
Treatment of  TNBL is like that of  other nonthoracic 
neuroblastomas (3). It is based on tumor stage and biologi-
cal properties, and is largely risk-oriented (1, 3). Low-risk 
patients with localized tumors achieve excellent results with 
resection alone, whereas higher-risk patients with distant 
disease require chemotherapy or radiotherapy in addition 
to surgery (2). Radical surgery is rarely indicated, and the 
goal of  surgery should be to achieve the preservation of  
anatomy as much as the resection of  tumor (3, 4). Recent 
studies have shown there to be no difference in 5-year sur-
vival rate or event-free survival among patients undergoing 
complete or incomplete resection (3, 4). Accordingly, com-
plete resection may not be a necessary treatment goal (4). 
While posterolateral thoracotomy has been the traditional 
surgical approach and has good prognosis, it is also associ-
ated with a long recovery period and high surgical morbid-
ity (8). Recently, thoracoscopy has been employed with ap-
parent success. It offers surgeons better visualization of  the 
anatomy while providing patients with cosmetic advantages 
and shorter hospital stays (8).
TNBL is an unusual presentation of  neuroblastoma. Al-
though it is outnumbered by abdominal neuroblastomas at 
a level of  three to one, it is still the most common mediasti-
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Figure 4. 9-day-old infant with thoracic neuroblastoma. I-
123 MIBG nuclear medicine scan. Note abnormal uptake in 
the left chest (green arrow) and normal uptake in the liver 
(red arrowhead).
nal mass in children under two years. TNBL should always 
be included in the differential diagnosis of  young children 
presenting with movement disorders or nystagmus that is 
difficult to explain (3). Since tumor treatment depends 
highly on staging, multimodal imaging with an emphasis on 
MRI is critical to patient outcomes. 
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